• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results

    Prellis Biologics' New Tool Simplifies Complex Tissue Engineering

    InspireMD's CEO Steps Down

    Celmatix Sues Research Partner 23andMe for $100M

    FDA Cleared New Cochlear Osia 2 System
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    GS Plastic Optics

    RJG Inc.

    Nelson Laboratories LLC

    S-Y-M Products Company

    Marox Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Zeus

    S-Y-M Products Company

    FUTEK Advanced Sensor Technology Inc.

    Lyons

    GS Plastic Optics
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Medical Auto-Pilot: Medtech’s Focus on Digital Therapeutics

    Medical Auto-Pilot: Medtech’s Focus on Digital Therapeutics
    RespondWell has developed a platform and software to provide physical therapy at home by leveraging technology from the video game industry. Image courtesy of RespondWell.
    Related CONTENT
    • FlowAid Receives FDA Clearance for the FA100 SCCD
    • Four Common Misperceptions of Accelerated FDA Approval
    • AdvaMedDx Statement on the Diagnostic Accuracy and Innovation Act
    • The Tax that Wouldn’t Die
    • Extractable/Leachable Chemistry Testing Strategies for Medical Devices
    Bryan Hughes, Director, P&M Corporate Finance07.26.17
    Necessity is the mother of invention. Although often attributed to Plato and appearing in certain translations of his Republic, this well-known proverb more likely evolved from an early 1500s Latin textbook of everyday sayings that included the phrase “mater artium necessitas”—need is the mother of arts.

    Henry Ford faced this issue in the early 1900s. In 1907, he boldly promised to “build a car for the great multitude…so low in price that no man making a good salary will be unable to own one.” Unfortunately, automotive production methods back then jacked up the sticker price. Ford knew he would need to change the way cars were manufactured, and by December 1913, the Ford Motor Company had introduced the assembly line in its Highland Park plant.

    In healthcare, and specifically medical technology today, the same proverb holds true. As U.S. Senate Republicans worked through the July 4 holiday to rally enough votes to save their version of an Obamacare repeal, the Congressional Budget Office projected that 22 million Americans could become uninsured under the bill. Understandably, their Democratic counterparts and most media outlets seized on this report as the final nail to any immediate changes to the Affordable Care Act. What has been lost in the partisan debate, though, is the fact that just two years ago, the Medicare Access and CHIP Reauthorization Act (MACRA) passed in a decidedly bipartisan fashion.

    Among a number of other important provisions, MACRA requires the Centers for Medicare and Medicaid Services to begin implementing the Quality Payment Program, the agency’s most significant push toward value-based healthcare, and away from traditional fee-for-service models. While the Affordable Care Act included a number of similar components, MACRA has accelerated the value-based approach to healthcare.

    At their core, value-based and other shared-risk payment models are driven by the need to reduce healthcare costs. In 2014, the U.S. spent 17.5 percent of gross domestic product (roughly $3 trillion) on healthcare, but ranked 37th in the World Health Organization’s performance assessment of national health systems. The U.S. system is extremely complex, consisting of multiple stakeholders often having competing economic and care priorities. As such, the shift toward a fully value-based system is expected to take many years. To make this transition work, providers, physicians, payers, and even patients must rethink delivery—likely evolving toward more preventative and individualized continuum of care approaches. In fact, some bundled payment models have already shifted economic responsibility to providers for surgical patients for the period of time both before and after surgery. 

    To tie this all together, there is a tremendous need for smarter, more connected devices, data analytics, and predictive algorithms. The engagement tools between physician and patient have become more individualized and “consumerized,” while at the same time, the data needs of population-based risk management infrastructure rival those of more digitally advanced industries. In short, the necessity of driving down healthcare costs has created an entirely new segment of the medical device industry for digital therapeutics, and the largest, most established players are keenly, albeit cautiously, taking notice.

    While Henry Ford was developing a strategy to deliver his promised car to the great multitude, the speedometer was gradually becoming standard equipment on most vehicles. A half century later, Chrysler Corporation introduced auto pilot as the first broadly available cruise control on the 1958 Imperial. A Popular Science article that year questioned concerns whether robots [were] slowly taking over a driver’s “chores.” While those concerns seem overblown in hindsight, the conversion of analog tools (speedometer and cruise control) to integrated digital systems earlier this decade has, in fact, ushered in such advances as adaptive cruise control and autonomous vehicles. 

    For the medical device industry, the same digital revolution has enabled a new segment of connected, integrated therapeutics. These systems bring together the most advanced sensors and diagnostic technologies, along with new paradigms for preventative medicine, and coupled those with lessons from consumer electronics and other industries.

    While there are hundreds of digital therapeutic and connected device participants, the following examples highlight the investment approach more established medical device players are taking in the space as they cautiously watch the industry develop.

    RespondWell—Zimmer Biomet acquired the tele-rehabilitation firm in 2016 to enhance its Signature Solutions offering. While technically labeled as asynchronous telerehabilitation, RespondWell has developed a platform and software to provide physical therapy at home by leveraging technology from the video game industry. Digital instructors—think video game characters—lead patients through physical therapy sessions at their convenience. In turn, the platform relays video and other data to therapists who monitor progress virtually. Prior to being acquired, RespondWell had completed a small clinical study that showed there was no statistical difference between groups of patients that received physical therapy in an outpatient setting and those that did so virtually on the platform. 

    According to David Nolan of Zimmer Biomet, “The new value-based reimbursement environment compels hospitals and providers to assume responsibility for patient outcomes well after discharge and through the critical rehabilitation period…Integrating [RespondWell] into our Zimmer Biomet Signature Solutions offering addresses the emerging need for healthcare providers to oversee and optimize post-surgical recovery outcomes in order to maximize value across the entire episode of care.”

    Omada Health—Over the last five years, Omada has raised more than $125 million from a network of prominent VC firms as well as strategic investors including Cigna, GE Ventures, Humana, Kaiser Permanente, Providence Health & Services, and Sanofi-Genzyme. Omada’s focus is helping patients alter certain behaviors or habits that may put them at increased risk for chronic conditions like type 2 diabetes and heart disease. The basic science behind Omada’s first product, Prevent, is based on the Diabetes Prevention Program.

    Prevent combines a wireless scale that is synched with each participant’s account, professional health coaches and peer groups, and interactive lessons about making healthier choices. While a digital scale is not novel and doesn’t really stretch the capabilities of today’s contract manufacturers, what is novel is that the program itself has been evaluated in a number of peer-reviewed studies. As digital therapeutics grow in prevalence, we expect outcomes data to be a key gating item for potential acquisition by larger strategic players.

    Proteus Digital Health—While many digital therapeutics are still trying to map the appropriate regulatory pathway with the U.S. Food and Drug Administration (FDA), Proteus has actually received two FDA clearances. Its ingestible sensor was approved in 2012, and its sensor-laden external patch was cleared in 2010. These approvals, coupled with a huge addressable market in medication management and adherence, have allowed Proteus to raise almost $500 million in funding. Most interesting, large strategic players across multiple segments of healthcare have invested including Medtronic plc, St. Jude Medical Inc., Itochu, Kaiser Permanente, Novartis, and even enterprise software company Oracle.

    According to Proteus, medication non-adherence often cascades into uncontrolled health conditions that cost the U.S. healthcare system an estimated $290 billion annually. With the company’s Discover system, patients swallow specially formulated medications containing the ingestible sensor. These sensors transmit data to an external patch worn on the torso that, in turn, communicates with the cloud, where the information can be accessed.

    Glooko—Recent rumors suggest Medtronic is interested in acquiring Glooko, which has developed a digital health solution for diabetes. Much of this speculation is based on Medtronic’s participation in the most recent round of funding for the company, which has also secured investments from Insulet, the Mayo Clinic, and Samsung.

    Glooko’s core hardware is the MeterSync Blue proprietary cable that allows a patient to sync information from more than 30 blood glucose monitors with their mobile device. Like other digital health or therapeutic solutions, Glooko then uploads this information to the cloud, allowing patients to better manage their diabetes and providing clinicians access to real-time glucose readings between clinic visits.

    Kenzen—The Kenzen Echo Smart Patch continuously monitors various vital signs by analyzing small beads of sweat. Originally developed for the European Space agency, the non-invasive patch is designed to be worn on the torso and can measure water concentrations of electrolytes like sodium and potassium, metabolites, glucose, various molecules, and proteins. Strategic investors in Kenzen include Flex (formerly Flextronics) and the San Francisco 49ers.

    Gecko Health—Gecko Health was acquired by Teva Pharmaceuticals in September 2015. Teva acquired Gecko primarily for its CareTRx technology, which combines sensors that attach to most asthma inhalers, an accessible user interface, and behavioral triggers to help asthma and chronic obstructive pulmonary disease patients manage their condition. More than just seeking technology, Teva acquired Gecko for its people in order to develop a core capability in digital therapeutics and continues to evaluate multiple technologies within respiratory digital health.

    IntelliRod—Although not as well-known as other industry players, IntelliRod recently announced a license agreement with the Cleveland Clinic around smart implants and is working with OhioHealth on an intelligent back brace. According to company press releases, the Cleveland Clinic IP will be coupled with IntelliRod’s expertise in microelectronics and inductive power to create a therapeutic spinal implant device with integrated sensors.

    The work with OhioHealth is focused on advancing technology invented there by neurosurgeon Dr. Chris Karas, who said, “Intellirod is focused on collecting the data surgeons need to achieve better outcomes for our patients. This type of technology is currently lacking, but is absolutely necessary to get people back to work and back to life.”  The IntelliBrace technology would allow for remote monitoring of post-surgical spine patients by autonomously collecting data from the company’s ACCUVISTA rod strain sensor, thus providing information to improve patient compliance and decrease certain complications. 


    Bryan Hughes is a director of PMCF and leads the firm’s medical technology team. His practice focuses on assisting clients with mergers and acquisitions, leveraged buyouts, private placements, financings, valuation and strategic consulting. His clients have ranged from global medical technology companies to small, privately held businesses.
    Related Searches
    • ingestible sensor
    • heart
    • medtronic plc
    • monitoring
    Related Knowledge Center
    • Diagnostics
    • Patient Monitoring
    • Digital Health
    Suggested For You
    Top 30 Global Medical Device Companies Top 30 Global Medical Device Companies
    FDA Clears First Neonatal MRI Device FDA Clears First Neonatal MRI Device
    Medtronic’s TAVR Access Expanded with FDA Approval Medtronic’s TAVR Access Expanded with FDA Approval
    World World's Smallest Pacemaker Passes Space Test
    World World's Smallest Pacemaker to Be Tested in Space Flight
    On the Way to Over-the-Counter Hearing Aids On the Way to Over-the-Counter Hearing Aids
    Medtronic Launches ‘Artificial Pancreas’ Hybrid Closed Loop System in U.S. Medtronic Launches ‘Artificial Pancreas’ Hybrid Closed Loop System in U.S.
    Class III Devices from 10,000 Feet: The Big Picture on Getting Premarket Approval Class III Devices from 10,000 Feet: The Big Picture on Getting Premarket Approval
    Midyear Medtech Review Midyear Medtech Review
    Shockwave Medical Appoints President and CEO Shockwave Medical Appoints President and CEO
    FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers
    Medtronic Launches Resolute Onyx Drug-Eluting Stent in U.S. Medtronic Launches Resolute Onyx Drug-Eluting Stent in U.S.
    Medtronic Launches Advanced StealthStation for Neurosurgery Medtronic Launches Advanced StealthStation for Neurosurgery
    FDA Designates Medtronic Action as Class I Recall FDA Designates Medtronic Action as Class I Recall
    Medtronic Divests Technology to Cardinal Health for $6.1 Billion Medtronic Divests Technology to Cardinal Health for $6.1 Billion

    Related Columns

    • Diagnostics
      From Genome Sequencing to the World’s First Portable MRI

      From Genome Sequencing to the World’s First Portable MRI

      Dr. Jonathan Rothberg has risen about as high as a scientist can, save for the Nobel Prize.
      Sam Brusco, Associate Editor 11.04.19

    • Digital Health
      An Update on Digital Health

      An Update on Digital Health

      Sure, most are startups—but not all. There were some brilliant ideas presented at The MedTech Conference (AdvaMed’s annual meeting) on Sept. 23-25 in Boston and the Connected Health Conference, also in Boston, put on by Partners Health…
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.19

    • Diagnostics
      Elizabeth Holmes: The Making of a Pop Culture Icon

      Elizabeth Holmes: The Making of a Pop Culture Icon

      Despite keeping a relatively low profile this year (not by choice), Elizabeth Holmes’ celebrity status has continued to grow.
      Michael Barbella, Managing Editor 10.08.19


    • Contract Manufacturing | Digital Health | Software & IT
      Connecting the Dots in Medical Device Outsourcing

      Connecting the Dots in Medical Device Outsourcing

      San Francisco is globally renowned for many things: The Golden Gate Bridge (its color, international orange, was actually a primer used to protect the steel during transit), Ghirardelli chocolate, the TransAmerica pyramid building, and the “Pai…
      MPO Staff 07.30.19

    • Digital Health | Neurological
      A Breakthrough for the Nightmarish Effects of PTSD

      A Breakthrough for the Nightmarish Effects of PTSD

      Though I am not a particularly strong supporter of Apple—and you’re welcome to contact me to find out why—I have to admit the Apple Watch could be a useful tool for proactive health monitoring. The Apple Watch Series 4, released…
      Sam Brusco, Associate Editor 06.13.19

    • Digital Health
      AI in Healthcare: Where Are We Now?

      AI in Healthcare: Where Are We Now?

      At the 5th Annual World Medical Innovation Forum (WMIF), hosted by Partners HealthCare, three days of panels and presentations highlighted new applications of artificial intelligence (AI) machine learning and natural language processing technologies…
      Maria Shepherd, President and Founder, Medi-Vantage 06.13.19


    • Cardiovascular | Diagnostics | Digital Health | Patient Monitoring
      Cardiac Care on the Can

      Cardiac Care on the Can

      Transitioning from reactive to proactive/preventive care could work wonders for the healthcare system. A proactive strategy is important for cardiovascular disease, the leading cause of death across the globe. According to a 2017 American Heart Asso…
      Sam Brusco, Associate Editor 04.03.19

    • Digital Health | Patient Monitoring
      Converging Goals: How a Focus on the Patient Drives Stronger Healthcare Partnerships

      Converging Goals: How a Focus on the Patient Drives Stronger Healthcare Partnerships

      The foundation of healthcare is shifting from a provider-based to a patient-centric—or value-based—model. With aging populations, better-informed patients, and emerging technologies, the responsibilities and roles of every stakeholder in…
      Vicki Anastasi, VP and Global Head—Medical Device and Diagnostics Research & Real World Evidence Late Phase Research, ICON 04.03.19

    • Diagnostics | Digital Health
      Google’s Search for Direction in Healthcare

      Google’s Search for Direction in Healthcare

      Fake news, begone: Reports of Alphabet’s healthcare struggles have not been greatly exaggerated. That bears repeating: Not been greatly exaggerated. Indeed, Google’s parent company is foundering a bit in its attempt to claim a signi…
      Michael Barbella, Managing Editor 03.07.19


    • 3D/Additive Manufacturing | Digital Health
      Discerning Medtech’s Path in 2019

      Discerning Medtech’s Path in 2019

      It’s the dawn of another year, and that means it’s time to engage in the unavoidable pastime of prognostication. Predicting the future isn’t easy, but it can be fun and oftentimes insightful. One of the most rewarding aspects of pro…
      Mark Bonifacio, President, BCS LLC 01.31.19

    • Digital Health
      A Primer for Manufacturers Adjusting to Value-Based Healthcare

      A Primer for Manufacturers Adjusting to Value-Based Healthcare

      Value-based healthcare (VBHC) models are poised to transform everything from how patient care is delivered to how treatments are priced. A 2016 analysis by UnitedHealthcare estimated that at the end of 2018, more than $65 billion would be tied to val…
      Vicki Anastasi, VP and Global Head, Medical Device and Diagnostics Research, ICON 01.31.19

    • Digital Health
      2019 Preview: Predicting the Trends and Their Potential Impact on Business Plans

      2019 Preview: Predicting the Trends and Their Potential Impact on Business Plans

      The prognosticators are at it again. With 2019 well underway, industry pundits are deeply ensconced in a longstanding New Year’s tradition—predicting the trends and developments likely to impact medtech over the next 12 months (and beyond…
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 01.30.19

    • Digital Health
      What a Long, Strange Trip It’s Been…

      What a Long, Strange Trip It’s Been…

      Who could have predicted all the changes we have seen in medtech in the 15 years since 2003? In 2003, pacemakers were only used in cardiology. Since then, modifications of early pacemaker technology have erupted into the neurostimulation market. In M…
      Maria Shepherd, President and Founder, Medi-Vantage 06.04.18

    • Diagnostics | Materials | Patient Monitoring
      Diabetes Management and the Role of Adhesives

      Diabetes Management and the Role of Adhesives

      Diabetes management has come a long way over the past few decades. The disease that used to require patients to visit their doctor’s office on a weekly basis for glucose readings can now be continuously monitored on-the-go in the office or at h…
      Del R. Lawson, Ph.D., R&D manager, Critical and Chronic Care Solutions Division, 3M 06.04.18

    • Digital Health
      Mobile Medical Applications: The Regulatory Framework in the U.S. and the EU

      Mobile Medical Applications: The Regulatory Framework in the U.S. and the EU

      The medical device market is one of the largest industries in the healthcare sector, which has seen significant growth in the last 15 years. Harnessing the benefits of the digital revolution and medical technology, the industry is in a state of conti…
      Sudeep Kolluri, Solutioning Lead, Freyr 06.04.18


    Breaking News
    • 15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results
    • Prellis Biologics' New Tool Simplifies Complex Tissue Engineering
    • InspireMD's CEO Steps Down
    • Celmatix Sues Research Partner 23andMe for $100M
    • FDA Cleared New Cochlear Osia 2 System
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Beckers Group Announces Global Price Increase on Coil, Industrial Coatings
    Evonik, Wynca Celebrate Groundbreaking of New Fumed Silica Plant in Zhenjiang
    Personnel Changes in Corporate Communications, Government Relations at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results
    Prellis Biologics' New Tool Simplifies Complex Tissue Engineering
    InspireMD's CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    CatSci Expands Capabilities with Lab Expansion
    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence
    PCI Pharma Services Invests in Tredegar, UK Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Happi

    Latest Breaking News From Happi

    Birchbox Partners with Buzzfeed
    Coty Strengthens Its Leadership
    Jennifer Garner Joins Virtue Labs
    Ink World

    Latest Breaking News From Ink World

    Smurfit Kappa, Wings for Aid Create Disaster Relief Packaging Solution
    ePac Flexible Packaging Expands into Asia Pacific Market
    United Carton Industries Company Invests in EFI Nozomi Corrugated Printer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Mark Andy joins forces with UPM Raflatac
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Simavita Set to License Sensor Technology in EU
    NDC Appoints President
    AATC Adds Two Scholarships
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    TriMed Closes Out FDA Warning Letter
    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Releases Global Semiconductor Equipment Sales Forecast
    eMagin Corporation Announces Approximately $4.3 Million Order for Military Program
    CPI Supports Smart Food-labeling Project Set to Reduce Food Waste in 2020

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.